Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Vion pursues prodrugs of 3-AP with superior biological, pharmaceutical properties

Dec. 29, 1998

Resveratrol shown to bind to and cleave DNA

Dec. 29, 1998

U.S. clinical trials of SU-6668 slated for early 1999

Dec. 29, 1998

Isis obtains antisense cancer rights from Genzyme Molecular Oncology

Dec. 28, 1998

First convincing data for extended therapeutic gene expression by human stem cells

Dec. 28, 1998

In vivo safety and efficacy of photodynamic therapy evaluated by Theratechnologies in CML patients

Dec. 28, 1998

Gliadel Wafer approved in Canada and France

Dec. 28, 1998

New cancer-linked gene licensed by Corixa from MIT

Dec. 23, 1998

Preliminary phase II results for Incel + paclitaxel in refractory breast cancer

Dec. 23, 1998

Orphan drug status given to Immunomedics' CEA-Cide pancreatic cancer therapeutic

Dec. 23, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...